Neeka Health Canada (NHC) is the Canadian clinical subsidiary of Neeka Enterprises (NE) that is built on the scientific underpinnings of research by Dr. Amin Kassam and Dr. Rich Rovin.

With over four decades of experience, along with the broader NHC team, they provide experience in multiple domains, including: clinical trial design, molecular cell signaling and cell engineering, bioinformatics and patient-empowered and patient-owned data management digital health systems to transform the lives of patients suffering from post-concussion neurological diseases.
Canopy Growth Corporation

NHL Alumni Association strikes deal with cannabis company for medical exams, brain scans

The NHL Alumni Association has signed a landmark agreement with Canopy Growth Corp., that will see the Canadian cannabis company finance one or more studies that could be an important step towards establishing the first comprehensive snapshot of the health of retired hockey players. Canopy Growth has agreed to cover the costs of a double …

Canopy Growth, NHLA, NEEKA collaboration

NHL Alumni Association Teams Up With Canopy Growth to Research Concussions and Cannabinoids

New study led by NEEKA Health Canada will test if CBD-based therapies can reduce the severity of post-concussion brain disorders in former NHL players. March 2, 2019 TORONTO & SMITHS FALLS, ON — NHL Alumni Association (NHLAA), NEEKA Health Canada and Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) are pleased to announce a transformative …